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CARDIOPULMONARY BYPASS, MYOCARDIAL 
MANAGEMENT, AND SUPPORT TECHNIQUES 
REGIONAL GENERATION 
OF FREE OXYGEN 
RADICALS DURING 
CARDIOPULMONARY 
BYPASS IN CHILDREN 
Studies on free radical generation during eardiopulmonary b pass have 
focused  mainly on the heart and the lungs. However, low pumping pressure, 
nonpulsatile perfusion, and hypothermia ffect the entire circulation, 
resulting in decreased splanchnic blood flow, increased intestinal perme- 
ability, and endotoxemia. To evaluate regional phenomena, we studied 16 
children undergoing cardiopulmonary bypass. Free radical production, 
granulocyte activation, and hypoxanthine metabolism were assessed sepa- 
rately in the circulations drained by the inferior and superior venae cavae, 
as weil as in the oxygenator. Three minutes after the onset of cardiopul- 
monary bypass, significant gradients between the inferior vena cava and the 
arterial ine of the oxygenator existed in malondialdehyde (+0.60  - 0.12 
/.tmol/L, lactoferrin (+18.21 + 7.65 /.ig/L), myeloperoxidase (+53.75 -+ 
16.50 btg/L), hypoxanthine (-0.62 _ 0.15/.tmol/L), and urate (+8.87 - 4.03 
Bmol/L). These gradients decreased in parallel with decreasing body 
temperature. Except for a transient gradient in malondialdehyde at 3 
minutes after the onset of cardiopulmonary b pass  (+0.23  - 0.08 pmol/L), 
no changes were detected between th  superior vena cava and the arterial 
line. In the oxygenator, granulocyte activation was observed only after 
aortic declamping. We conclude that during cardiopulmonary bypass, 
significant free radical generation, granulocyte activation, hypoxanthine 
elimination, and urate production take place in the region drained by the 
inferior vena cava. In the oxygenator, granulocyte activation occurs only 
after aortic declamping. (J THORAC CARDIOVASC SURG 1995;110:768-73) 
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I ncreased free radical activity during cardiopulmo- 
nary bypass (CPB) has been associated with myo- 
cardial and pulmonary dysfunction. 1 CPB activates 
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the complement system, which leads to granulocyte 
activation and free radical production. 2 During isch- 
emia, the enzyme xanthine dehydrogenase is con- 
verted to xanthine oxidase, in which form it gener- 
ates free radicals as by-products during metabolism 
of hypoxanthine and xanthine to urate)  
Interest in free radical activity during cardiac 
operations has focused on the heart and the lungs, 
because they are exposed to ischemia and subse- 
quent reperfusion during CPB. However, low pump- 
ing pressure, nonputsatile perfusion, and hypother- 
mia cause considerable hemodynamic hanges in 
the entire circulation. During hypothermic perfu- 
sion in animal models, cerebral, renal, and splanch- 
nic flows diminish and femoral artery flow increases. 4 
Recent smdies in human beings how a 46% reduction 
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Table I. Patient data 
Number 16 
Sex 
Male 9 
Female 7 
Age (yr) 2.99 (0.49-4.71) 
Weight (kg) 11.6 (5.8-19.0) 
Diagnosis 
Ventricular septal defect 5 
Tetralogy of Fallot 3 
Univentricular heart 3 
Aortic valve insufficiency 2 
Transposition of great arteries 1 
Mitral valve insufficiency 1 
Pulmonary valve stenosis 1 
Crossclamping time (min) 65 (27-117) 
Duration of CPB (min) 99 (53-164) 
in gastric mucosal blood flow during CPB. 5 Splanchnic 
hypoperfusion may cause increased intestinal perme- 
ability and endotoxemia. 5' 6 If free radicals play a role 
in these changes, increased free radical activity may be 
measurab]e in venous return from the splanchnic 
region. 
This study was conducted to evaluate regional 
changes in free radical activity and its two potential 
sources, granulocyte activation and xanthine metab- 
olism, during CPB in chi]dren. 
Methods 
Patients. We studied 16 children undergoing CPB for 
elective repair of congenital heart defects (Table I). All 
the patients were in stable condition during the induction 
and preinduction phases. 
Anesthesia and operation. Patients were premedicated 
with flunitrazepam (0.1 mg/10 kg p.o.). Anesthesia was 
induced with fentanyl, thiopentone sodium or ketamine, 
and pancuronium and maintained with a high dose of 
fentanyl (50-100 txg/kg). Isoflurane was administered if 
needed. CPB was established with the use of a Masterflo 
34 (<15 kg) or a Masterflo 51 (>15 kg) pediatric hollow- 
fiber membrane oxygenator and a Midicard 20B cardiot- 
omy reservoir (Dideco S.p.A., Mirandola, Italy). A roller 
pump (Gambro, Lund, Sweden) was used with a standard 
flow of 2.4 L/min per square meter (at 37 ° C), which was 
then reduced to match the requirements according to the 
degree of hypothermia. Circulatory arrest was used in one 
patient; postarrest values for this patient were excluded. 
Barbiturates or steroids to protect the brain were not 
given. 
A prime solution comprising albumin and fresh whole 
blood was used to adjust the hematocrit value to 25%. 
During rewarming, hemofiltration (Ultraflux 400 filter, 
Fresenius, Germany) was used consistently and uniformly 
to increase the hematocrit value to at least 30%. To 
achieve this, we added fresh whole blood, if needed. 
Mannitol (15%) was administered as an infusion of 1 
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Fig. 1. Mixed venous concentrations of malondialdehyde 
(MDA), hypoxanthine (HX), urate (UR), lactoferrin (LF), 
and myeloperoxidase (MPO). Preoperative values cor- 
rected for hemodilution during CPB are depicted with 
dots. tp < 0.05, t?p < 0.01, and t?tP < 0.001 versus 0 
minutes; *p < 0.05 and **p < 0.01 versus 40 minutes after 
the onset of CPB (Wilcoxon test). 
ml/kg per hour from the beginning of the perfusion. The 
protein inhibitor aprotinin (30,000 IU/kg) was added in 
the priming solution, and the same amount also was 
infused for 1 hour after the induction of anesthesia. 
Infusion of aprotinin (8000 IU/kg per hour) was continued 
throughout CPB. For myocardial preservation, cold 
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Table II. Differences in parameters between IVC or 
SVC and the arterial Iine of the oxygenator (A) 
Diff eYegl«es 
Time after 
Parameter onset of CPB IVC-A SVC-A 
MDA 3 min 0.60 ± 0.12"* 0.23 -+ 0.08* 
(txmol/L) 20 min 0.36 _+ 0.13" 0.06 + 0.09 
HX 3 min -0.62 _+ 0.15"* 0.06 _+ 0.09 
(/xmol/L) 20 min -0.24 _+ 0.66 0.18 + 0.44 
UR 3 min 8.87 + 4.03* 2.00 _+ 2.31 
0zmol/L) 20 min 9.93 + 5.79** 5.00 + 6.87 
LF 3 min 18.21 _+ 7.65* 0.51 ± 5.45 
(/xg/L) 20 min 0.94 _+ 42.63 -1.46 - 16.33 
MPO 3 min 53.75 + 16.50'* 2.60 ± 11.23 
(/zg/L) 20 min 17.63 -+ 51.91 16.00 _+ 27.19 
CPB, cardiopulmonary b pass; MDA, malondialdehyde; 
thine; UR, urate; LF, lactoferrin; MPO, myeloperoxidase. 
*p < 0.05; **p < 0.01. 
HX, hypoxan- 
(+40 C) blood cardioplegic solution (30 ml/kg) was used 
initially and repeated (10 tal/kg) every 20 minutes. On the 
decision of the surgeon, the last cardioplegic solution (300 
ml/m2), containing 2mmol/100 ml aspartate and 2 mmol/ 
100 ml glutamate ("hot shot'), was infused immediately 
before aortic declamping. None of the patients received 
allopurinol. Whole body temperature was assessed by 
measuring mixed venous temperature. 
Sample colleetion. Blood samples were collected after 
induction of anesthesia but before the operation began; at 
3, 20, and 40 minutes after the onset of CPB; and at 2, 7, 
and 12 minutes after aortic declamping. Blood samples 
were obtained simultaneously from radial arterial and 
central venous catheters before CPB and from the supe- 
rior (SVC) and inferior (IVC) venae cavae and from the 
arterial and venous lines (mixed venous value) of the 
oxygenator during CPB. Samples specifically from the 
IVC were obtained by means of a side line on the IVC 
cannula, and samples from the SVC were obtained 
through a central venous catheter, the tip of which was 
placed in the SVC. The CPB cannulation and snaring of 
the vessel proximally prevented blood in the SVC from 
mixing with blood from the IVC. The samples collected in 
tubes containing ethylenediaminetetraacetic acid were 
immediately centrifuged for 5 minutes at 1000 g. An 
aliquot of 150/xl of plasma for malondialdehyde m asure- 
ment was immediately added to 15 tzl of deferoxamine 100 
mg/ml (Desferal, Ciba-Geigy, Basel, Switzerland). The 
samples were stored at -70 ° C. 
Assays. Hypoxanthine was quantified with high-pres- 
sure liquid chromatography, urate by a Hitachi 705E 
device (Hitache Ltd., Tokyo, Japan) by an enzymatic 
method, lactoferrin and myeloperoxidase by radioimmu- 
nology, and malondialdehyde by measurement of thiobar- 
bituric acid-reactive material. 71° 
Statistical analysis. Plasma concentrations were calcu- 
lated both corrected and uncorrected for hematocrit 
value. Within CPB, hemodilution did not have a signifi- 
cant effect on results. Therefore results during CPB are 
presented only uncorrected. Pre-CPB values are given 
both uncorrected and corrected to correspond with the 
hemodilution of the first sample during CPB. In statistical 
analysis, the two-tailed Wilcoxon test and analysis of 
variance (ANOVA) were used. A p value less than 0.05 
was considered significant. Patient data are presented as 
median and range. Results are presented either as indi- 
vidual values or as mean _+ standard error of the mean. 
Ethics. The study was approved by the ethics commit- 
tee of the Children's Hospital, University of Helsinki, and 
informed consent was obtained from the parents. 
Results 
Malondialdehyde. After the onset of CPB, there 
was an apparent decrease in mixed venous malon- 
dialdehyde concentration compared with preopera- 
tive values, but after correction for hemodilution 
during CPB, this difference disappeared (Fig. 1, A). 
At 3 minutes after the onset of CPB, malondialde- 
hyde concentration was higher in the SVC than in 
the arterial ine of the oxygenator (Table Il). At 3 
and 20 minutes after the onset of CPB, malondial- 
dehyde concentration was higher in the IVC than in 
the arterial ine of the oxygenator (Table II and Fig. 
2, B). This difference diminished gradually with 
decreasing body temperature (Fig. 2, B). No differ- 
ences could be detected between the arterial and 
venous lines of the oxygenator. 
Hypoxanthine. At 3 minutes after the onset of 
CPB, mixed venous hypoxanthine concentration was 
already increased, and it became elevated further 
after aortic declamping (Fig. 1, B). During the entire 
period of CPB, there were no differences in hypo- 
xanthine concentration between the SVC and the 
arterial line of the oxygenator nor between the 
arterial and venous lines of the oxygenator (Table 
II). At 3 minutes after the onset of CPB, hypoxan- 
thine concentration was significantly lower in the 
IVC than in the arterial line of the oxygenator 
(Table I I  and Fig. 2, C). Significant differences in the 
same direction were also observed 2, 7, and 12 
minutes after aortie declamping (p = 0.0174, p = 
0.0022, and p = 0.0024, respectively). 
Urate. Compared with preoperative values, the 
mixed venous coneentration of urate deereased dur- 
ing CPB, but not if corrected for hemodilution (Fig. 
1, C). No differences in urate eoncentration were 
observed between the SVC and the arterial ine of 
the oxygenator, nor between the arterial and venous 
lines of the oxygenator (see Table II). Urate content 
was higher in the IVC than in the arterial ine of the 
oxygenator at 3 and 20 minutes after the onset of 
CPB (Table I I  and Fig. 2, C) and at 2 minutes after 
aortie deelamping (p = 0.0025). 
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Fig. 2. Mixed venous temperature (V-TEMP) and differ- 
ences in plasma concentrations of malondialdehyde 
(MDA), hypoxanthine (HX), urate (UR), lactoferrin (LF), 
and myeloperoxidase (MPO) between the IVC and the 
arterial ine of the oxygenator. ?p < 0.05 and ?tp < 0.01 
for IVC versus A (Wileoxon test). 
Lactoferrin and myeloperoxidase. Mixed venous 
concentrations of both lactoferrin and myeloperox- 
idase increased significantly during CPB (Fig. 1, D 
and E). Further increase of laetoferrin concentra- 
tion occurred after aortic declamping (Fig. 1, D). No 
differences in lactoferrin or myeloperoxidase con- 
centration were observed between the SVC and the 
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Fig. 3. Plasma lactoferrin (LF) and myeloperoxidase 
(MPO) concentration differences between arterial and 
venous lines of the oxygenator. ?p < 0.05 and ?tP < 0.01 
for arterial versus venous line (Wileoxon test). 
arterial line of the oxygenator (Table II). At 3 
minutes after the onset of CPB, both lactoferrin and 
myeloperoxidase w re higher in the IVC than in the 
arterial ine of the oxygenator (Table II and Fig. 2, 
D and E). This difference diminished gradually with 
decreasing body temperature (Fig. 2, D and E). Both 
lactoferrin and myeloperoxidase concentrations 
were higher in the arterial than in the venous line of 
the oxygenator after aortic declamping, but not 
during crossclamping (Fig. 3). 
Discussion 
This study demonstrates increased granulocyte 
activation, hypoxanthine metabolism, and free rad- 
ical generation during CPB in the circulation 
drained by the IVC. The magnitudes of these phe- 
nomena decrease in parallel with decreasing body 
temperature. 
We did not detect any increase in lipid peroxida- 
tion, measured as malondialdehyde concentration, 
during the entire CPB period. This is consistent with 
a recent study. 11 Increased malondialdehyde pro- 
duction after aortic declamping has been demon- 
strated in blood samples obtained from the left 
atrium, that is, in blood drained speeifically from the 
pulmonary circulation. Iz Those results may not be 
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eompared with the mixed venous concentrations 
measured in this study. Although no systemic in- 
erease in malondialdehyde was detected in this 
study, a transient increase was found at the start of 
CPB in both the SVC and the IVC. 
We found a very rapid increase in hypoxanthine 
as early as 3 minutes after the onset of CPB. The 
most probable xplanation is cellular hypoxia caused 
by hypoperfusion. ~3 Despite seemingly adequate 
central hemodynamics and oxygenation during car- 
diac operations, peripheral tissue perfusion is re- 
stricted, as suggested by an increase in arterial 
concentration of lactate after the onset of CPB. 14 
During reperfusion after aortic declamping, we ob- 
served a further increase in hypoxanthine, probably 
reflecting washout of hypoxanthine accumulated in 
ischemic myocardial and pulmonary tissues. The 
finding is in accordance with earlier observations of
hypoxanthine liberation after transient cardiac isch- 
emia, during reperfusion i cardiac operations, and 
during heart-lung transplantation. 15-17 
Xanthine oxidase/dehydrogenase activities vary 
between organs. In this study, at 3 minutes after the 
onset of CPB and at 2 minutes after aortic declamp- 
ing, hypoxanthine d creased and urate increased in 
the IVC hut not in the SVC. This result is compat- 
ible with high xanthine oxidase/dehydrogenase ac- 
tivity in splanchnic organs but low or no activity in 
skeletal muscle and brain, is' 19 
CPB leads to rapid intravascular g anulocyte ac- 
tivation, presumably caused by complement activa- 
tion through the alternative pathway when plasma 
contacts the unphysiologic surfaces of the oxygen- 
ator.2, 20 However, granulocytic degranulation, in- 
dicative of granulocyte activation, has not previously 
been measured in the oxygenator. We found a rapid 
increase in lactoferrin and myeloperoxidase concen- 
trations from the beginning of CPB. At the begin- 
ning of CPB, degranulation was localized not to the 
oxygenator but to the circulation drained by the 
IVC. Only after aortic declamping did significant 
degranulation take place in the oxygenator, and it 
was temporally associated with further increase 
in mixed venous plasma lactoferrin. The finding is 
in accordance with data showing a release of sev- 
eral leukocyte-activating factors only after aortic 
declamping.21, 2 
On the basis of this study, the precise origin of 
increased malondialdehyde or degranulation pro- 
teins in the IVC cannot be determined. In a canine 
model, a decrease in body temperature decreases 
splanchnie and renal perfusion but increases per- 
fusion through the femoral artery. 4 Decreased 
splanchnic perfusion during hypothermia has re- 
cently been documented also in human beings, 5In 
out patients, hypoxanthine concentration decreased 
and urate concentration i creased in the IVC 3 
minutes after the onset of perfusion, while hypo- 
thermia still was relatively mild. As body tempera- 
ture decreased, these differences disappeared. This 
may reflect a shift of perfusion from splanchnic 
organs containing xanthine oxidase/dehydrogenase 
to lower extremities in which the enzyme activity is 
low. is This mechanism could also account for the 
changes in myeloperoxidase, lactoferrin, and malon- 
dialdehyde concentrations i  the IVC in relation to 
decreasing mixed venous temperature. Endotox- 
emia caused by intestinal damage has been associ- 
ated with CPB, and intestinal permeability increases 
3 hours after elective coronary artery bypass graft- 
ing.5, 6 Our results uggest that increased splanchnic 
granulocyte activation and free radical actMty dur- 
ing CPB may have pathophysiologic relevance to the 
intestinal damage associated with cardiac operations. 
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